Data as of Dec 19
| -0.09 / -2.32%|
The 3 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +177.04% increase from the last price of 3.79.
The current consensus among 3 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.